Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
PLoS One. 2010 Nov 23;5(11):e14102. doi: 10.1371/journal.pone.0014102.
Histone H3 lysine 4 (K4) methylation is a prevalent mark associated with transcription activation and is mainly catalyzed by the MLL/SET1 family histone methyltransferases. A common feature of the mammalian MLL/SET1 complexes is the presence of three core components (RbBP5, Ash2L and WDR5) and a catalytic subunit containing a SET domain. Unlike most other histone lysine methyltransferases, all four proteins are required for efficient H3 K4 methylation. Despite extensive efforts, mechanisms for how three core components regulate MLL/SET1 methyltransferase activity remain elusive. Here we show that a heterodimer of Ash2L and RbBP5 has intrinsic histone methyltransferase activity. This activity requires the highly conserved SPRY domain of Ash2L and a short peptide of RbBP5. We demonstrate that both Ash2L and the MLL1 SET domain are capable of binding to S-adenosyl-L- [methyl-(3)H] methionine in the MLL1 core complex. Mutations in the MLL1 SET domain that fail to support overall H3 K4 methylation also compromise SAM binding by Ash2L. Taken together, our results show that the Ash2L/RbBP5 heterodimer plays a critical role in the overall catalysis of MLL1 mediated H3 K4 methylation. The results we describe here provide mechanistic insights for unique regulation of the MLL1 methyltransferase activity. It suggests that both Ash2L/RbBP5 and the MLL1 SET domain make direct contacts with the substrates and contribute to the formation of a joint catalytic center. Given the shared core configuration among all MLL/SET1 family HMTs, it will be interesting to test whether the mechanism we describe here can be generalized to other MLL/SET1 family members in the future.
组蛋白 H3 赖氨酸 4(K4)甲基化是一种普遍存在的与转录激活相关的标记,主要由 MLL/SET1 家族组蛋白甲基转移酶催化。哺乳动物 MLL/SET1 复合物的一个共同特征是存在三个核心成分(RbBP5、Ash2L 和 WDR5)和一个含有 SET 结构域的催化亚基。与大多数其他组蛋白赖氨酸甲基转移酶不同,所有四个蛋白对于有效的 H3 K4 甲基化都是必需的。尽管进行了广泛的研究,但三个核心成分如何调节 MLL/SET1 甲基转移酶活性的机制仍不清楚。在这里,我们表明 Ash2L 和 RbBP5 的异二聚体具有内在的组蛋白甲基转移酶活性。这种活性需要 Ash2L 的高度保守 SPRY 结构域和 RbBP5 的短肽。我们证明 Ash2L 和 MLL1 SET 结构域都能够与 MLL1 核心复合物中的 S-腺苷-L-[甲基-(3)H]甲硫氨酸结合。不能支持整体 H3 K4 甲基化的 MLL1 SET 结构域突变也会使 Ash2L 结合 SAM 受到影响。总之,我们的结果表明,Ash2L/RbBP5 异二聚体在 MLL1 介导的 H3 K4 甲基化的整体催化中发挥关键作用。我们在这里描述的结果为 MLL1 甲基转移酶活性的独特调节提供了机制上的见解。这表明 Ash2L/RbBP5 和 MLL1 SET 结构域都与底物直接接触,并有助于形成联合催化中心。鉴于所有 MLL/SET1 家族 HMTs 都具有共享的核心结构,未来测试我们在这里描述的机制是否可以推广到其他 MLL/SET1 家族成员将是很有趣的。